182 related articles for article (PubMed ID: 24121375)
1. PET and PET/CT imaging in thyroid and adrenal diseases: an update.
Treglia G; Giovanella L; Rufini V
Hormones (Athens); 2013; 12(3):327-33. PubMed ID: 24121375
[TBL] [Abstract][Full Text] [Related]
2. Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers.
Wong KK; Arabi M; Zerizer I; Al-Nahhas A; Rubello D; Gross MD
Nucl Med Commun; 2011 Sep; 32(9):764-81. PubMed ID: 21799367
[TBL] [Abstract][Full Text] [Related]
3. The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview.
Treglia G; Muoio B; Giovanella L; Salvatori M
Eur Arch Otorhinolaryngol; 2013 May; 270(6):1783-7. PubMed ID: 23053387
[TBL] [Abstract][Full Text] [Related]
4. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by
Suh CH; Choi YJ; Lee JJ; Shim WH; Baek JH; Chung HC; Shong YK; Song DE; Sung TY; Lee JH
Thyroid; 2017 Oct; 27(10):1258-1266. PubMed ID: 28791924
[TBL] [Abstract][Full Text] [Related]
6. Cervix carcinoma and incidental finding of medullary thyroid carcinoma by 18F-FDG PET/CT--clinical case.
Chaushev B; Bochev P; Klisarova A; Yordanov K; Encheva E; Dancheva J; Yordanova C; Hristozov K; Krasnaliev I; Radev R; Nenkov R
Nucl Med Rev Cent East Eur; 2014; 17(2):97-100. PubMed ID: 25088110
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic strategy of incidental findings of focal thyroid FDG uptake identified on PET/CT].
Nielsen MH; Nygaard B; Søndergaard SB; Bennedbæk FN
Ugeskr Laeger; 2011 Aug; 173(33):1948-52. PubMed ID: 21849133
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
[TBL] [Abstract][Full Text] [Related]
9. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Brindle R; Mullan D; Yap BK; Gandhi A
Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of patterns of incidental thyroid uptake at (18)F-FDG PET/CT.
Agrawal K; Weaver J; Ngu R; Krishnamurthy Mohan H
Clin Radiol; 2015 May; 70(5):536-43. PubMed ID: 25687827
[TBL] [Abstract][Full Text] [Related]
12. Adrenal tuberculosis masquerading as disseminated malignancy: A pitfall of (18)F-FDG PET/CT Imaging.
Gorla AK; Gupta K; Sood A; Biswal CK; Bhansali A; Mittal BR
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):257-9. PubMed ID: 26853485
[TBL] [Abstract][Full Text] [Related]
13. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
14. The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.
Lang BH; Law TT
Oncologist; 2011; 16(4):458-66. PubMed ID: 21378078
[TBL] [Abstract][Full Text] [Related]
15. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
[TBL] [Abstract][Full Text] [Related]
17. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
Salvatori M; Biondi B; Rufini V
Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
[TBL] [Abstract][Full Text] [Related]
18. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG PET/CT of adrenal lesions.
Dong A; Cui Y; Wang Y; Zuo C; Bai Y
AJR Am J Roentgenol; 2014 Aug; 203(2):245-52. PubMed ID: 25055255
[TBL] [Abstract][Full Text] [Related]
20. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]